PFE vs. MRK
Compare and contrast key facts about Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PFE or MRK.
Correlation
The correlation between PFE and MRK is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PFE vs. MRK - Performance Comparison
Key characteristics
PFE:
-0.32
MRK:
-1.38
PFE:
-0.30
MRK:
-1.86
PFE:
0.97
MRK:
0.75
PFE:
-0.13
MRK:
-0.86
PFE:
-0.63
MRK:
-1.65
PFE:
12.38%
MRK:
21.30%
PFE:
24.26%
MRK:
25.66%
PFE:
-58.96%
MRK:
-68.62%
PFE:
-56.70%
MRK:
-38.54%
Fundamentals
PFE:
$127.78B
MRK:
$198.72B
PFE:
$1.41
MRK:
$6.74
PFE:
15.88
MRK:
11.68
PFE:
0.53
MRK:
0.72
PFE:
2.01
MRK:
3.10
PFE:
1.44
MRK:
4.28
PFE:
$48.75B
MRK:
$48.39B
PFE:
$31.22B
MRK:
$39.64B
PFE:
$12.18B
MRK:
$19.98B
Returns By Period
In the year-to-date period, PFE achieves a -12.72% return, which is significantly higher than MRK's -19.05% return. Over the past 10 years, PFE has underperformed MRK with an annualized return of 0.39%, while MRK has yielded a comparatively higher 7.14% annualized return.
PFE
-12.72%
-10.84%
-17.89%
-7.85%
-4.33%
0.39%
MRK
-19.05%
-9.14%
-23.33%
-35.27%
3.69%
7.14%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PFE vs. MRK — Risk-Adjusted Performance Rank
PFE
MRK
PFE vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PFE vs. MRK - Dividend Comparison
PFE's dividend yield for the trailing twelve months is around 7.42%, more than MRK's 3.96% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 7.42% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% |
MRK Merck & Co., Inc. | 3.96% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
Drawdowns
PFE vs. MRK - Drawdown Comparison
The maximum PFE drawdown since its inception was -58.96%, smaller than the maximum MRK drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for PFE and MRK. For additional features, visit the drawdowns tool.
Volatility
PFE vs. MRK - Volatility Comparison
The current volatility for Pfizer Inc. (PFE) is 10.19%, while Merck & Co., Inc. (MRK) has a volatility of 10.96%. This indicates that PFE experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PFE vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Pfizer Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities